Groundbreaking perfection

Analytical specifications 

Molderm’s revolutionary technology is based on over 40 years of scientific evidence and several years of research and data.

Molderm® is one of the most well-developed products on the market in fillers and biostimulating products. In the development of Molderm®, we have learned from the history of the beauty industry and with the help of the progress and success of science, we have been able to develop a product series that is well-balanced and adapted to the needs of each indication.

Molderm® Classic, Exact, Strong and Lips, maintain the same concentration of HA in order for the products to be absolutely homogeneous with one another. This removes all risk of edema reactions that may occur when products at different concentrations are used during the same treatment.

The difference between the Molderm® products, and therefore also different indications and duration, depend solely on the applied degree of cross-linking in combination with our unique configuration – the Fine-Tuning Technology™. Molderm® is built on incredibly pure raw material (Pharma Grade), cutting-edge production techniques, original physical-chemical measures, multi-cross-linking, and fractional sterilization.

Analytical Specifications

ACTIVE COMPONENT

Cross-linked Hyaluronic Acid

CONCENTRATION

20 mg/ml 

RETICULANT AGENT

BDDE (residual <0,4 ppm)

RETICULATION GRADE

**HA

DYNAMIC VISCOSITY

520.000 mPa.s

ELASTICITY

<0,430 w (w = 1 1/s)

SYRINGE VOLUME

1,0 ml

PH

6,50-7,50

NEEDLE

27G 1/2 Inch

PROTEIC LEVEL

<2 ppm

ENDOTOXINS

<0,025 IU/mg

APPEARANCE

Colourless, Transparent

Analytical Specifications

ACTIVE COMPONENT

Cross-linked Hyaluronic Acid

CONCENTRATION

20 mg/ml 

RETICULANT AGENT

BDDE (residual <0,4 ppm)

RETICULATION GRADE

***HA

DYNAMIC VISCOSITY

870.000 mPa.s

ELASTICITY

<0,460 w (w = 1 1/s)

SYRINGE VOLUME

1,0 ml

PH

6,50-7,50

NEEDLE

27G 1/2 Inch

PROTEIC LEVEL

<2 ppm

ENDOTOXINS

<0,025 IU/mg

APPEARANCE

Colourless, Transparent

Analytical Specifications

ACTIVE COMPONENT

Cross-linked Hyaluronic Acid

CONCENTRATION

20 mg/ml 

RETICULANT AGENT

BDDE (residual <0,4 ppm)

RETICULATION GRADE

****HA

DYNAMIC VISCOSITY

1.150.000 mPa.s

ELASTICITY

<0,500 w (w = 1 1/s)

SYRINGE VOLUME

1,0 ml

PH

6,50-7,50

NEEDLE

27G 1/2 Inch

PROTEIC LEVEL

<2 ppm

ENDOTOXINS

<0,025 IU/mg

APPEARANCE

Colourless, Transparent

Analytical Specifications

ACTIVE COMPONENT

Cross-linked Hyaluronic Acid

CONCENTRATION

20 mg/ml 

RETICULANT AGENT

BDDE (residual <0,4 ppm)

RETICULATION GRADE

***HA

DYNAMIC VISCOSITY

870.000 mPa.s

ELASTICITY

<0,460 w (w = 1 1/s)

SYRINGE VOLUME

1,0 ml

PH

6,50-7,50

NEEDLE

27G 1/2 Inch

PROTEIC LEVEL

<2 ppm

ENDOTOXINS

<0,025 IU/mg

APPEARANCE

Colourless, Transparent

Analytical Specifications

ACTIVE COMPONENT

Non-crosslinked hyaluronic acid

CONCENTRATION

20 mg/ml

SODIUM HYALURONATE

18,0 – 21,0 mg/ml

MOLECULAR WEIGHT

From low to ultra high

SPECTRAL FOCUS

Mid ultra high region

INTRINSIC VISCOSITY

1,9 – 3,2 m³/kg

APPEARANCE

Clear ABS 600 ≤ 0,01

STERILITY

Sterile

SYRINGE VOLUME

2,0 ml

PH

6,8 – 7,6

NEEDLE

30G 1/2 inch

ENDOTOXINS TEST

<0,5 EU/ml

Analytical Specifications

ACTIVE COMPONENT

Non-crosslinked hyaluronic acid

CONCENTRATION

20 mg/ml

SODIUM HYALURONATE

23,0 – 26,0 mg/ml

MOLECULAR WEIGHT

From low to ultra high

SPECTRAL FOCUS

Upper ultra high region

INTRINSIC VISCOSITY

1,9 – 3,2 m³/kg

APPEARANCE

Clear ABS 600 ≤ 0,01

STERILITY

Sterile

SYRINGE VOLUME

2,0 ml

PH

6,8 – 7,6

NEEDLE

30G 1/2 inch

ENDOTOXINS TEST

<0,5 EU/ml

Molecular spectrum focus for GLOW och GLOW+

LOW
HIGH
ULTRA HIGH
Analytical Specifications

All MOLDERM® products can be combined with each other during the same session, for exemplary results.

A gel that does NOT require lidocaine!

With Molderms patented technology together with Swiss high-tech manufacturing and quality processes, an HA gel is created that is nearly identical to human hyaluronic acid.

This, in combination with world-leading raw materials, provides a filler without reactions, swelling and migration.
For the patient, this means a much more pleasant experience with injection.
Our international Post Market Study shows that 80% of patients experience less pain with Molderm® without lidocaine compared to other brands without lidocaine.
Molderm® without lidocaine together with applied cold or anesthetic cream reduces all risks associated with lidocaine and increases control of the injected gel.

WORLD WIDE DISTRIBUTION

Molderm® is distributed via and ONLY by an exclusive distribution network to ensure the same quality and identity, shared values, and concept, no matter where you are located. You only have the opportunity to order your Molderm® products from the distributor who is responsible for the territory you are located in. Click on “see distributor list” down below to find your distributor.

Interested in getting exclusive distribution rights of Molderm® in your country? Please click on “become a distributor” for application and initial contact.

Analytical Specifications